Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
UC Davis Cancer Center Renews Prestigious NCI Designation
Research & Development UC Davis Cancer Center Renews Prestigious NCI Designation

In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially

Bioengineered Conduits Show Promise for Coronary Bypass Surgery
Research & Development Bioengineered Conduits Show Promise for Coronary Bypass Surgery

A major hurdle in cardiac surgery is the compliance mismatch between stiff artificial tubes and flexible arteries, which creates turbulent blood flow and eventual graft blockage. This fundamental discrepancy has long prevented the widespread adoption of synthetic bypass grafts, as the sudden change

How Is Truveta Scaling the Learning Health System?
Tech & Innovation How Is Truveta Scaling the Learning Health System?

The convergence of big data and clinical medicine is finally enabling the creation of a system where every patient encounter contributes to collective medical knowledge. As healthcare providers grapple with the sheer volume of information generated within their networks, the ability to synthesize

Can Lab-Grown Brain Organoids Reveal the Secrets of Aging?
Biotech & Bioprocessing Can Lab-Grown Brain Organoids Reveal the Secrets of Aging?

The internal chronology of the human brain appears to be a negotiation between hardwired genetic programs and the external environment rather than a purely reactive state. This realization marks a significant departure from traditional neurobiology, which often viewed the brain as a plastic organ

Can a Metastasis-on-a-Chip Transform Cancer Research?
Biotech & Bioprocessing Can a Metastasis-on-a-Chip Transform Cancer Research?

By integrating a selectively permeable endothelial lining, this new technology forces cancer cells to demonstrate their ability to traverse vessel walls. This breakthrough represents a monumental shift in oncology, moving away from the static culture plates and animal models that have dominated

How Is COFEPRIS Digitizing Medical Device Regulation?
Management & Regulatory How Is COFEPRIS Digitizing Medical Device Regulation?

This digital initiative addresses long-standing inefficiencies by providing a public mechanism to verify the legal status of medical devices sold throughout the country. For many years, the Mexican medical device market struggled with a lack of transparency, where paper-based records led to

Can New Treatments Replace Rectal Cancer Surgery?
Research & Development Can New Treatments Replace Rectal Cancer Surgery?

International researchers have identified a five-week chemoradiotherapy protocol that allows four out of five patients to avoid major surgery while maintaining their quality of life. This paradigm shift in oncology marks a departure from the traditional approach, where radical excision was

Safe Stem Cell Transplant Methods for Cold Agglutinin Disease
Research & Development Safe Stem Cell Transplant Methods for Cold Agglutinin Disease

Standard laboratory protocols for washing and preparing harvested stem cells must be modified with pre-warmed solutions to prevent thermal shock in sensitive biological samples. This requirement becomes critically apparent when treating patients with Cold Agglutinin Disease (CAD), a rare autoimmune

Role of the MDCK Assay in Predicting Drug Permeability
Tech & Innovation Role of the MDCK Assay in Predicting Drug Permeability

A molecule may show exceptional potency against a biological target in a test tube yet fail completely if it cannot cross the lipid-rich cell membrane. This fundamental reality of pharmacokinetics has established the Madin-Darby Canine Kidney assay as a cornerstone of early-stage pharmaceutical

How Can Mankind Pharma Balance ESG Growth and Global Scaling?
Management & Regulatory How Can Mankind Pharma Balance ESG Growth and Global Scaling?

The company reported a consolidated revenue of ₹4,031 crore for the first quarter of fiscal year 2027, reflecting a significant 12.89% annual growth. This financial achievement underscores the robust performance of its domestic portfolio, which continues to outpace the general Indian pharmaceutical

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later